EUVIMEDEUVIMED entdecken
Crossref

HMA/VEN: A New Pretransplant Paradigm for SOME People with AML

Edward A Copelan, Robert P Gale, Belinda R Avalos

Transplantation and Cellular Therapy · 2026-05 · 32 (5) · 513-514

DOI: 10.1016/j.jtct.2026.04.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation and Cellular Therapy, 2026-05. Verfasst von Edward A Copelan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA. El…. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA. Electronic address: Edward.copelan@atriumhealth.org.
  • Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA.

Zitieren

APA

Copelan, E. A., Gale, R. P., & Avalos, B. R. (2026). HMA/VEN: A New Pretransplant Paradigm for SOME People with AML. Transplantation and Cellular Therapy, 32(5), 513-514. https://doi.org/10.1016/j.jtct.2026.04.014

Vancouver

Copelan EA, Gale RP, Avalos BR. HMA/VEN: A New Pretransplant Paradigm for SOME People with AML. Transplantation and Cellular Therapy. 2026;32(5):513-514. doi:10.1016/j.jtct.2026.04.014

BibTeX
@article{Copelan2026,
  author = {Copelan, Edward A and Gale, Robert P and Avalos, Belinda R},
  title = {HMA/VEN: A New Pretransplant Paradigm for SOME People with AML},
  journal = {Transplantation and Cellular Therapy},
  year = {2026},
  volume = {32},
  number = {5},
  pages = {513--514},
  doi = {10.1016/j.jtct.2026.04.014}
}
Kostenlos starten →